RTA compliance certificate for quarter ended September 2026

Compliance View source PDF Explain this filing

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.3%Reaction day

₹115.50

prior close

₹114.13

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+1.5% vs market

Hospital peers, median of 26sector-2.3%+1.0% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 1.0 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.3-2.8+1.5-2.3+1.0

Next day

-1.7-2.5+0.8-0.8-0.9

-6.1-1.7-4.4-1.2-4.9

-4.8-1.5-3.3-2.2-2.6

-3.1-0.8-2.3-1.7-1.4

-4.6-2.4-2.2-2.3-2.4

-4.8-3.4-1.4-3.8-0.9

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lotus Eye Hospital has submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate from registrar MUFG Intime India confirms that all share dematerialisation requests received from depository participants during the quarter were processed, confirmed or rejected, and listed on the stock exchanges. Cancelled physical certificates were mutilated and the depository names were updated in the register of members within the prescribed timelines. This is a standard quarterly procedural filing.

Likely market impact

Routine regulatory compliance filing. No impact on business, financials, or share price.